We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$5.92B
AUM Growth
+$68.4M
Cap. Flow
+$113M
Cap. Flow %
1.91%
Top 10 Hldgs %
13.29%
Holding
305
New
36
Increased
153
Reduced
102
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 17.09%
2 Industrials 15.36%
3 Financials 13.68%
4 Healthcare 13.26%
5 Consumer Discretionary 12.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWD icon
201
Woodward
WWD
$21.1B
$5.97M 0.1%
83,271
-258
-0.3% -$19.4K
MIME
202
DELISTED
Mimecast Limited
MIME
$5.87M 0.1%
165,768
+40,364
+32% +$1.37M
FORR icon
203
Forrester Research
FORR
$225M
$5.77M 0.1%
139,207
+173
+0.1% +$7.38K
HMSY
204
DELISTED
HMS Holdings Corp.
HMSY
$5.75M 0.1%
341,403
+5,978
+2% +$100K
GBT
205
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.74M 0.1%
118,809
-26,908
-18% -$1.5M
PLAY icon
206
Dave & Buster's
PLAY
$349M
$5.54M 0.09%
132,729
-57
-0% -$2.63K
FOXF icon
207
Fox Factory Holding Corp
FOXF
$905M
$5.36M 0.09%
153,621
-1,096
-0.7% -$41.6K
ZGNX
208
DELISTED
Zogenix, Inc.
ZGNX
$5.04M 0.09%
+125,908
New +$4.99M
KNX icon
209
Knight Transportation
KNX
$11.2B
$5.04M 0.09%
109,528
-514
-0.5% -$24.4K
DY icon
210
Dycom Industries
DY
$12.1B
$4.97M 0.08%
46,197
-342
-0.7% -$38.8K
CHUY
211
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$4.86M 0.08%
185,544
-2,514
-1% -$66.9K
CUB
212
DELISTED
Cubic Corporation
CUB
$4.7M 0.08%
73,903
-267
-0.4% -$16.3K
EPAY
213
DELISTED
Bottomline Technologies Inc
EPAY
$4.59M 0.08%
118,593
-243
-0.2% -$9.06K
FOLD
214
DELISTED
Amicus Therapeutics
FOLD
$4.46M 0.08%
296,891
-458
-0.2% -$6.97K
TVTX icon
215
Travere Therapeutics
TVTX
$5.68B
$4.3M 0.07%
192,153
+1,608
+0.8% +$38.3K
MMS icon
216
Maximus
MMS
$2.84B
$4.04M 0.07%
60,470
-269
-0.4% -$18.3K
DOVA
217
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$3.88M 0.07%
+142,895
New +$4.27M
PTLA
218
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.65M 0.06%
111,608
+20,206
+22% +$887K
BRKR icon
219
Bruker
BRKR
$8.69B
$3.52M 0.06%
117,692
-472
-0.4% -$15.3K
JELD icon
220
JELD-WEN Holding
JELD
$164M
$3.42M 0.06%
+111,781
New +$4.05M
DBVT
221
DBV Technologies
DBVT
$885M
$3.25M 0.05%
14,064
+225
+2% +$53.2K
CSII
222
DELISTED
Cardiovascular Systems, Inc.
CSII
$3M 0.05%
136,760
+862
+0.6% +$20.7K
HRTG icon
223
Heritage Insurance Holdings
HRTG
$957M
$2.38M 0.04%
157,049
-399
-0.3% -$6.83K
THR
224
DELISTED
Thermon Group Holdings
THR
$2.3M 0.04%
102,818
-1,007
-1% -$23.2K
ICLR icon
225
Icon
ICLR
$12.8B
$1.65M 0.03%
13,941
+2,445
+21% +$280K

Similar funds

GW&K Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, GW&K Investment Management held 305 positions worth $5.92B, up 1.2% from $5.85B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

GW&K Investment Management's Q1 2018 filing shows 36 new, 153 increased, 102 reduced and 13 closed positions. Its largest new stake was PacWest Bancorp: 731,320 shares worth $36.2M. The largest sale was West Pharmaceutical, an estimated $50.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • GW&K Investment Management's largest Q1 2018 buy was PacWest Bancorp: 731,320 shares worth $36.2M.
  • GW&K Investment Management added most to Praxair Inc in Q1 2018, an estimated $18.1M increase.
  • GW&K Investment Management's biggest Q1 2018 reduction was West Pharmaceutical, cutting an estimated $50.4M.
  • GW&K Investment Management fully exited Cincinnati Financial in Q1 2018, selling an estimated $37.8M.
  • GW&K Investment Management's ten largest holdings make up 13% of its $5.92B portfolio in Q1 2018.
  • GW&K Investment Management opened 36 new positions and closed 13 in Q1 2018.
  • GW&K Investment Management's portfolio value rose 1.2% quarter-over-quarter to $5.92B.

Based on GW&K Investment Management's 13F filing for Q1 2018, filed 8 May 2018.